<VariationArchive VariationID="3247744" VariationName="NC_000001.10:g.(?_45794978)_(45799285_?)del" VariationType="Deletion" Accession="VCV003247744" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1421790" VariationID="3247744">
      <GeneList>
        <Gene Symbol="MUTYH" FullName="mutY DNA glycosylase" GeneID="4595" HGNC_ID="HGNC:7527" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45329242" stop="45340440" display_start="45329242" display_stop="45340440" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45794913" stop="45806141" display_start="45794913" display_stop="45806141" Strand="-" />
          </Location>
          <OMIM>604933</OMIM>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NC_000001.10:g.(?_45794978)_(45799285_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p34.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" innerStart="45794978" innerStop="45799285" display_start="45794978" display_stop="45799285" variantLength="4308" />
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000001.10:g.(?_45794978)_(45799285_?)del AND Familial adenomatous polyposis 2" Accession="RCV004584028" Version="1">
        <ClassifiedConditionList TraitSetID="1473">
          <ClassifiedCondition DB="MedGen" ID="C3272841">Familial adenomatous polyposis 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11818965</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12606733</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16557584</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17489848</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18534194</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19953527</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21962078</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23561487</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24953332</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1473" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1532" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="608456" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADENOMAS, MULTIPLE COLORECTAL, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="608456" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUTYH-associated polyposis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUTYH-related attenuated familial adenomatous polyposis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYH-associated polyposis</ElementValue>
                <Citation Type="review" Abbrev="Lindor, 2011">
                  <ID Source="PubMed">21325953</ID>
                </Citation>
                <XRef ID="MYH-associated+polyposis/8937" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adenomas, multiple colorectal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial adenomatous polyposis 2</ElementValue>
                <XRef ID="MONDO:0012041" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FAP type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FAP2</ElementValue>
                <XRef Type="MIM" ID="608456" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MAP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">MUTYH polyposis (also referred to as MUTYH-associated polyposis, or MAP) is characterized by a greatly increased lifetime risk of colorectal cancer (CRC). Although typically associated with ten to a few hundred colonic adenomatous polyps, CRC develops in some individuals in the absence of polyposis. Serrated adenomas, hyperplastic/sessile serrated polyps, and mixed (hyperplastic and adenomatous) polyps can also occur. Duodenal adenomas are common, with an increased risk of duodenal cancer. The risk for malignancies of the ovary and bladder is also increased, and there is some evidence of an increased risk for breast and endometrial cancer. Additional reported features include thyroid nodules, benign adrenal lesions, jawbone cysts, and congenital hypertrophy of the retinal pigment epithelium.</Attribute>
                <XRef ID="NBK107219" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10805" />
                <XRef ID="10805" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987420</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23035301</ID>
                <ID Source="BookShelf">NBK107219</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/ESMO, 2015">
                <ID Source="PubMed">25452455</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24310308</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Familial-Adenomatous-Polyposis-ACT-Sheet.aspx</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APC Pathogenic Variants (Familial Adenomatous Polyposis [FAP]), 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/cg118</URL>
                <CitationText>UK NICE Clinical Guideline CG118, Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <XRef ID="220460" DB="Orphanet" />
              <XRef ID="247798" DB="Orphanet" />
              <XRef ID="C3272841" DB="MedGen" />
              <XRef ID="MONDO:0012041" DB="MONDO" />
              <XRef Type="MIM" ID="608456" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9838286" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000001.10:g.(?_45794978)_(45799285_?)del|MedGen:C1837991" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005065144" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21962078</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23561487</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24953332</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11818965</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12606733</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16557584</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17489848</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18534194</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19953527</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 3-16 of the MUTYH gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. A similar copy number variant has been observed in individual(s) with polyposis and colorectal cancer (PMID: 21962078, 23561487, 24953332). This variant disrupts the p.Tyr179 amino acid residue in MUTYH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11818965, 12606733, 16557584, 17489848, 18534194, 19953527). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.(?_45794978)_(45799285_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1837991" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9838286" TraitType="Disease" MappingType="XRef" MappingValue="C1837991" MappingRef="MedGen">
        <MedGen CUI="C3272841" Name="Familial adenomatous polyposis 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

